A mutation in the c-Fos gene associated with congenital generalized lipodystrophy

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Knebel, Birgit ^a   Kotzka, Jorg ^a   Lehr, Stefan ^a   Hartwig, Sonja ^a   Avci, Haluk ^a   Jacob, Sylvia ^a   Nitzgen, Ulrike ^a   Schiller, Martina ^a   März, Winfried ^b,c   Hoffmann, Michael M ^d   Seemanova, Eva ^e   Haas, Jutta ^f   Muller Wieland, Dirk ^f  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c SYNLAB ACADEMY   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e CHARLES UNIVERSITY   (Czech Republic)

^f Budapest An der Schön Klinik Hamburg Eilbek Dehnhaide   (Germany)

Author keywords

Congenital lipodystrophy; Immediate early genes; Protein DNA interaction; Transcriptional regulation

Indexed keywords

INSULIN;

ARTICLE; CELL ISOLATION; CONGENITAL GENERALIZED LIPODYSTROPHY; CONTROLLED STUDY; DNA PROTEIN COMPLEX; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IN VITRO STUDY; INSULIN RESISTANCE; MASS SPECTROMETRY; ONCOGENE C FOS; POINT MUTATION; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WILD TYPE;

ADIPOCYTES; ADULT; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION; GENES, FOS; GENES, IMMEDIATE-EARLY; HUMANS; LIPODYSTROPHY, CONGENITAL GENERALIZED; POINT MUTATION;

EID: 84881050385     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-119     Document Type: Article

References (36)

1. Clinical and molecular aspects of Berardinelli-Seip Congenital Lipodystrophy (BSCL). Gomes KB, Pardini VC, Fernandes AP, Clin Chim Acta 2009 402 1 6 10.1016/j.cca.2008.12.032 19167372
2. Genetic basis of lipodystrophies and management of metabolic complications. Agarwal AK, Garg A, Annu Rev Med 2006 57 297 311 10.1146/annurev.med.57.022605.114424 16409151 (Pubitemid 43261993)
3. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, Mitsuhashi S, Park YE, Nonaka I, Hino-Fukuyo N, Haginoya K, Sugano H, Nishino I, J Clin Invest 2009 119 2623 2633 10.1172/JCI38660 19726876
4. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. Hegele RA, Joy TR, Al-Attar SA, Rutt BK, J Lipid Res 2007 48 1433 1444 10.1194/jlr.R700004-JLR200 17374881 (Pubitemid 47312005)
5. Human lipodystrophies: genetic and acquired diseases of adipose tissue in Levy-Marchal C, Pénicaud L (eds) adipose tissue development: from animal models to clinical conditions. Capeau J, Magré J, Caron-Debarle M, Lagathu C, Antoine B, Béréziat V, Lascols O, Bastard JP, Vigouroux C, Endocr Dev Basel, Karger 2010 19 1 20
6. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. Ristow M, Müller-Wieland D, Pfeiffer A, Krone W, Kahn CR, N Engl J Med 1998 339 953 959 10.1056/NEJM199810013391403 9753710 (Pubitemid 28455097)
7. Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation. Caron M, Auclair M, Sterlingot H, Kornprobst M, Capeau J, AIDS 2003 17 2437 2444 10.1097/00002030-200311210-00005 14600514 (Pubitemid 38393315)
8. Mouse models of inherited lipodystrophy. Savage DB, Dis Model Mech 2009 2 554 562 10.1242/dmm.002907 19892886
9. Transcriptional factors that promote formation of white adipose tissue. White UA, Stephens JM, Mol Cell Endocrinol 2010 318 10 14 10.1016/j.mce.2009.08. 023 19733624
10. Chromatin accessibility and transcription factor binding at the PPARγ2 promoter during adipogenesis is protein kinase A-dependent. Xiao H, Leblanc SE, Wu Q, Konda S, Salma N, Marfella CG, Ohkawa Y, Imbalzano AN, J Cell Physiol 2011 226 86 93 10.1002/jcp.22308 20625991
11. Reduced phosphorylation of transcription factor Elk-1 in cultured fibroblasts of a patient with premature aging syndrome and insulin resistance. Knebel B, Avci H, Bullmann C, Kotzka J, Müller-Wieland D, Exp Clin Endocrinol Diabetes 2005 113 94 101 10.1055/s-2004-830554 15772901 (Pubitemid 40388780)
12. Phosphorylation of sterol regulatory element-binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes. Kotzka J, Knebel B, Avci H, Jacob S, Nitzgen U, Jockenhovel F, Heeren J, Haas J, Muller-Wieland D, Atherosclerosis 2010 213 156 165 10.1016/j.atherosclerosis.2010.08.046 20863500
13. c-fos transcriptional activation and repression correlate temporally with the phosphorylation status of TCF. Zinck R, Hipskind RA, Pingoud V, Nordheim A, EMBO J 1993 12 2377 2387 8389697 (Pubitemid 23194188)
14. Identification and validation of novel adipokines released from primary human adipocytes. Lehr S, Hartwig S, Lamers D, Famulla S, Müller S, Hanisch FG, Cuvelier C, Ruige J, Eckardt K, Ouwens DM, Sell H, Eckel J, Mol Cell Proteomics 2012 11 111.010504 10.1074/mcp.M111.010504 21947364
15. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Huang DW, Sherman BT, Lempicki RA, Nucleic Acids Res 2009 37 1 13 10.1093/nar/gkn923 19033363
16. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. da Huang W, Sherman BT, Lempicki RA, Nat Protoc 2009 4 44 57 19131956
17. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Kyriakis JM, Avruch J, Physiol Rev 2012 92 689 737 10.1152/physrev.00028.2011 22535895
18. Regulation of transcription by MAP kinase cascades. Treisman R, Curr Opin Cell Biol 1996 8 205 215 10.1016/S0955-0674(96)80067-6 8791420 (Pubitemid 26109094)
19. From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease. Ku CS, Tan EK, Cooper DN, J Med Genet 2013 50 203 211 10.1136/jmedgenet-2013-101519 23396985
20. UVB-induced DNA breaks interfere with transcriptional induction of c-fos. Ghosh R, Amstad P, Cerutti P, Mol Cell Biol 1993 13 6992 6999 8413289 (Pubitemid 23321151)
21. Ultraviolet A regulates adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells via up-regulation of Kruppel-like factor 2. Lee J, Lee J, Jung E, Kim YS, Roh K, Jung KH, Park D, J Biol Chem 2010 285 32647 3256 10.1074/jbc.M110.135830 20693579
22. Heterogeneous nuclear ribonucleoprotein R. Enhances transcription from the naturally configured c-fos promoter in vitro. Fukuda A, Nakadai T, Shimada M, Hisatake K, J Biol Chem 2009 284 23472 23480 10.1074/jbc.M109.013656 19581295
23. Nuclear functions of actin. Visa N, Percipalle P, Cold Spring Harb Perspect Biol 2010 2 000620 10.1101/cshperspect.a000620 20452941
24. Nulear actin is associated with a specific subset of hnRNP A/B-type proteins. Percipalle P, Jonsson A, Nashchekin D, Karlsson C, Bergman T, Guialis A, Daneholt B, Nucleic Acids Res 2002 30 1725 1734 10.1093/nar/30.8.1725 11937625 (Pubitemid 34679749)
25. A chromatin perspective of adipogenesis. Musri MM, Gomis R, Párrizas M, Organogenesis 2010 6 15 23 10.4161/org.6.1.10226 20592861
26. Heat shock factor 1 contains two functional domains that mediate transcriptional repression of the c-fos and c-fms genes. Xie Y, Zhong R, Chen C, Calderwood SK, J Biol Chem 2003 278 4687 4698 10.1074/jbc.M210189200 12468538 (Pubitemid 36800968)
27. Crosstalk of CREB and Fos/Jun on a single cis-element: transcriptional repression of the steroidogenic acute regulatory protein gene. Manna PR, Stocco DM, J Endocrin 2007 39 261 277 (Pubitemid 350047647)
28. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Venugopal R, Jaiswal AK, Proc Natl Acad Sci USA 1996 93 14960 14965 10.1073/pnas.93.25.14960 8962164 (Pubitemid 26419078)
29. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Johnson RS, Spiegelman BM, Papaioannou V, Cell 1992 71 577 586 10.1016/0092-8674(92)90592-Z 1423615
30. Bone and haematopoietic defects in mice lacking c-fos. Wang ZQ, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rüther U, Wagner EF, Nature 1992 360 741 745 10.1038/360741a0 1465144 (Pubitemid 23012271)
31. Apoptosis during castration-induced regression of the prostate is Fos dependent. Feng Z, Joos HJ, Vallan C, Mühlbauer R, Altermatt HJ, Jaggi R, Oncogene 1998 17 2593 2600 10.1038/sj.onc.1202195 9840922 (Pubitemid 28544700)
32. Bone and metabolism: a complex crosstalk. Lieben L, Callewaert F, Bouillon R, Horm Res 2009 71 134 138 10.1159/000178056 19153524
33. Adipogenesis: from stem cell to adipocyte. Tang QQ, Lane MD, Annu Rev Biochem 2012 81 715 736 10.1146/annurev-biochem-052110-115718 22463691
34. Elevated Fra-1 expression causes severe lipodystrophy. Luther J, Driessler F, Megges M, Hess A, Herbort B, Mandic V, Zaiss MM, Reichardt A, Zech C, Tuckermann JP, Calkhoven CF, Wagner EF, Schett G, David JP, J Cell Sci 2011 124 1465 1476 10.1242/jcs.079855 21486951
35. Radiological studies in generalized lipodystrophy. Westvik J, Acta Paediatr Suppl 1996 413 44 51 8783772
36. Downstream insulin-like growth factor. Pfäffle R, Kiess W, Klammt J, Endocr Dev 2012 201 42 51